Metabolic vulnerabilities and therapeutic opportunities in diffuse large B-cell lymphoma
Marie Anne-Catherine Neumann, Christian Frezza · 2026
Read Metabolic vulnerabilities and therapeutic opportunities in diffuse large B-cell lymphoma by Marie Anne-Catherine Neumann, Christian Frezza (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13179362.txt.
Description
Marie Anne-Catherine Neumann and Christian Frezza review how the metabolism of diffuse large B-cell lymphoma opens doors for new therapy. This fast lymphoma is the most common of its family, yet its biology varies widely between patients. Gene-based sorting has ruled care so far; fuel-use sorting may add a sharper axis.
Standard chemo-immunotherapy already hits tumor metabolism hard, though blindly. New drugs that block glucose, amino acid, fat, or mitochondrial pathways kill select lymphoma subsets in early work. The review weighs those agents and their fit with current regimens and immune tools such as CAR T cells. Tumor and immune cells fight over the same fuels, which shapes combo design. The authors urge trials that profile tumor fuel use and match drugs to it.
Catalog record
| CREATOR | Marie Anne-Catherine Neumann, Christian Frezza |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 64 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |